PE Tech Report


Like this article?

Sign up to our free newsletter

SV Life Sciences adds Paul Wallace as venture partner

SV Life Sciences has appointed Paul Wallace, an executive with over 18 years of experience in healthcare services operations and private equity investing, as a venture partner.

Wallace will be working on the SV Life Sciences healthcare services team.

Wallace was most recently senior vice president of Healthways, a Nashville-based provider of disease management, wellness and population health support solutions. His roles at Healthways included oversight of strategic planning, corporate development and sales and marketing.

Prior to Healthways, Wallace was a senior investment officer at Petra Capital in Nashville, Gilbert Global Equity Partners (fka Soros Capital) in New York, Lazard Asia Investment Management in Singapore, and GTCR in Chicago.

His principal investment experience includes more than 50 completed transactions representing over USD1.3bn of equity capital.

"We are very pleased to have Paul Wallace, a seasoned veteran of both the healthcare services and financial sectors, join the SV Life Sciences team as a venture partner," says Darren Black, SV Life Sciences partner. "Paul’s operations experience in growing a leading public healthcare service provider, coupled with his many years as a successful investment professional, will be a great asset to the SV Life Sciences healthcare services team."

Like this article? Sign up to our free newsletter